{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:15:13Z","timestamp":1790752513721,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.cellsig.2022.110331","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T11:39:20Z","timestamp":1649331560000},"page":"110331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies"],"prefix":"10.1016","volume":"94","author":[{"given":"Etienne","family":"Leveille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai N.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu-Sayeef","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"M\u00fcschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cellsig.2022.110331_bb0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrc.2017.111","article-title":"Autoimmunity checkpoints as therapeutic targets in B cell malignancies","volume":"18","author":"Muschen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.cellsig.2022.110331_bb0010","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","article-title":"ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile","volume":"101","author":"Wiestner","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cellsig.2022.110331_bb0015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/path.1727","article-title":"Immunohistochemical analysis of ZAP-70 expression in B-cell lymphoid neoplasms","volume":"205","author":"Carreras","year":"2005","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.cellsig.2022.110331_bb0020","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.molcel.2021.03.043","article-title":"Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer","volume":"81","author":"Sadras","year":"2021","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2022.110331_bb0025","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cell.2007.03.039","article-title":"Structural basis for the inhibition of tyrosine kinase activity of ZAP-70","volume":"129","author":"Deindl","year":"2007","journal-title":"Cell"},{"issue":"6544","key":"10.1016\/j.cellsig.2022.110331_bb0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/377032a0","article-title":"Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor","volume":"377","author":"Hatada","year":"1995","journal-title":"Nature"},{"issue":"30","key":"10.1016\/j.cellsig.2022.110331_bb0035","doi-asserted-by":"crossref","first-page":"23355","DOI":"10.1074\/jbc.M000404200","article-title":"Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T cell angigen receptor-mediated signaling","volume":"275","author":"Zhang","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.cellsig.2022.110331_bb0040","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ni1574","article-title":"Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance","volume":"9","author":"Oh-Hora","year":"2008","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.cellsig.2022.110331_bb0045","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1128\/MCB.19.3.2300","article-title":"Requirement for transcription factor NFAT in interleukin-2 expression","volume":"19","author":"Chow","year":"1999","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110331_bb0050","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4049\/jimmunol.168.6.2729","article-title":"CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K\/PKB signaling pathway in primary human T cells","volume":"168","author":"Appleman","year":"2002","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110331_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ni1161","article-title":"Calcium oscillations regulate thymocyte motility during positive selection in the three-dimensional thymic environment","volume":"6","author":"Bhakta","year":"2005","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110331_bb0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"issue":"6539","key":"10.1016\/j.cellsig.2022.110331_bb0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/376435a0","article-title":"Essential role for ZAP-70 in both positive and negative selection of thymocytes","volume":"376","author":"Negishi","year":"1995","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.cellsig.2022.110331_bb0070","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/ni.2918","article-title":"Quantitative and temporal requirements revealed for Zap70 catalytic activity during T cell development","volume":"15","author":"Au-Yeung","year":"2014","journal-title":"Nat. Immunol."},{"issue":"114","key":"10.1016\/j.cellsig.2022.110331_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000702","article-title":"Regulation of Zap70 expression during thymocyte development enables temporal separation of CD4 and CD8 repertoire selection at different signaling thresholds","volume":"3","author":"Saini","year":"2010","journal-title":"Sci. Signal."},{"issue":"12","key":"10.1016\/j.cellsig.2022.110331_bb0080","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/ni.1955","article-title":"A genetically selective inhibitor demonstrates a function for the kinase Zap70 in regulatory T cells independent of its catalytic activity","volume":"11","author":"Au-Yeung","year":"2010","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110331_bb0085","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.4049\/jimmunol.1400858","article-title":"Zap70 is essential for long-term survival of naive CD8 T cells","volume":"193","author":"Schim van der Loeff","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2022.110331_bb0090","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01310","article-title":"Distinct structural and catalytic roles for Zap70 in formation of the immunological synapse in CTL","volume":"3","author":"Jenkins","year":"2014","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.cellsig.2022.110331_bb0095","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1074-7613(03)00082-7","article-title":"Unexpected requirement for ZAP-70 in pre-B cell development and allelic exclusion","volume":"18","author":"Schweighoffer","year":"2003","journal-title":"Immunity"},{"issue":"6554","key":"10.1016\/j.cellsig.2022.110331_bb0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/378303a0","article-title":"Syk tyrosine kinase required for mouse viability and B-cell development","volume":"378","author":"Cheng","year":"1995","journal-title":"Nature"},{"issue":"6554","key":"10.1016\/j.cellsig.2022.110331_bb0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/378298a0","article-title":"Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk","volume":"378","author":"Turner","year":"1995","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2022.110331_bb0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1074-7613(00)80012-6","article-title":"BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells","volume":"10","author":"Ishiai","year":"1999","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cellsig.2022.110331_bb0115","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1182\/blood-2007-08-109769","article-title":"Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase","volume":"111","author":"Aiba","year":"2008","journal-title":"Blood"},{"issue":"46","key":"10.1016\/j.cellsig.2022.110331_bb0120","doi-asserted-by":"crossref","first-page":"32662","DOI":"10.1074\/jbc.274.46.32662","article-title":"SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling","volume":"274","author":"Beitz","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.cellsig.2022.110331_bb0125","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1084\/jem.20070405","article-title":"Distinct roles for Syk and ZAP-70 during early thymocyte development","volume":"204","author":"Palacios","year":"2007","journal-title":"J. Exp. Med."},{"issue":"37","key":"10.1016\/j.cellsig.2022.110331_bb0130","doi-asserted-by":"crossref","first-page":"22782","DOI":"10.1074\/jbc.271.37.22782","article-title":"Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases","volume":"271","author":"Latour","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110331_bb0135","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.cell.2013.08.009","article-title":"Lck availability during thymic selection determines the recognition specificity of the T cell repertoire","volume":"154","author":"Van Laethem","year":"2013","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2022.110331_bb0140","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.4049\/jimmunol.158.4.1650","article-title":"Protein tyrosine kinases Syk and ZAP-70 display distinct requirements for Src family kinases in immune response receptor signal transduction","volume":"158","author":"Zoller","year":"1997","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cellsig.2022.110331_bb0145","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2008.77","article-title":"Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas","volume":"22","author":"Feldman","year":"2008","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.cellsig.2022.110331_bb0150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/leu.2009.198","article-title":"Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin\u2019s lymphoma cell lines","volume":"24","author":"Wilcox","year":"2010","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.cellsig.2022.110331_bb0155","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20092042","article-title":"The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma","volume":"207","author":"Pechloff","year":"2010","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110331_bb0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.cellsig.2022.110331_bb0165","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"Crespo","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.cellsig.2022.110331_bb0170","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/sj.leu.2404363","article-title":"Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status","volume":"20","author":"Huttmann","year":"2006","journal-title":"Leukemia"},{"issue":"3 Pt 1","key":"10.1016\/j.cellsig.2022.110331_bb0175","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1158\/1078-0432.CCR-05-1531","article-title":"ZAP-70 expression in normal pro\/pre B cells, mature B cells, and in B-cell acute lymphoblastic leukemia","volume":"12","author":"Crespo","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2022.110331_bb0180","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1309\/WVQPVDF8UF7AV21X","article-title":"ZAP-70 expression in B-cell hematologic malignancy is not limited to CLL\/SLL","volume":"122","author":"Sup","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"issue":"8","key":"10.1016\/j.cellsig.2022.110331_bb0185","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/modpathol.3800145","article-title":"Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma","volume":"17","author":"Admirand","year":"2004","journal-title":"Mod. Pathol."},{"issue":"2","key":"10.1016\/j.cellsig.2022.110331_bb0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1751-553X.2007.00915.x","article-title":"ZAP-70 is highly expressed in most cases of childhood pre-B cell acute lymphoblastic leukemia","volume":"30","author":"Wandroo","year":"2008","journal-title":"Int. J. Lab. Hematol."},{"issue":"11","key":"10.1016\/j.cellsig.2022.110331_bb0195","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.20042101","article-title":"Mimicry of a constitutively active pre-B cell receptor in acute lymphoblastic leukemia cells","volume":"201","author":"Feldhahn","year":"2005","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2022.110331_bb0200","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccell.2015.02.003","article-title":"Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia","volume":"27","author":"Geng","year":"2015","journal-title":"Cancer Cell"},{"issue":"7277","key":"10.1016\/j.cellsig.2022.110331_bb0205","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"7418","key":"10.1016\/j.cellsig.2022.110331_bb0210","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2022.110331_bb0215","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1182\/blood-2015-11-681460","article-title":"Pathogenic role of B-cell receptor signaling and canonical NF-kappaB activation in mantle cell lymphoma","volume":"128","author":"Saba","year":"2016","journal-title":"Blood"},{"issue":"7415","key":"10.1016\/j.cellsig.2022.110331_bb0220","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature11309","article-title":"Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling","volume":"489","author":"Duhren-von Minden","year":"2012","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.cellsig.2022.110331_bb0225","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2002-06-1683","article-title":"Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia","volume":"100","author":"Chen","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cellsig.2022.110331_bb0230","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2006-03-011759","article-title":"ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells","volume":"109","author":"Gobessi","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cellsig.2022.110331_bb0235","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood-2006-12-062265","article-title":"ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia","volume":"111","author":"Chen","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellsig.2022.110331_bb0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/leu.2009.216","article-title":"Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70","volume":"24","author":"Zum Buschenfelde","year":"2010","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.cellsig.2022.110331_bb0245","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1182\/blood.2020009960","article-title":"ZAP-70 constitutively regulates gene expression and protein synthesis in chronic lymphocytic leukemia","volume":"137","author":"Chen","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cellsig.2022.110331_bb0250","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4065\/79.3.318","article-title":"Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia\/ small lymphocytic lymphoma","volume":"79","author":"Ghobrial","year":"2004","journal-title":"Mayo Clin. Proc."},{"issue":"9","key":"10.1016\/j.cellsig.2022.110331_bb0255","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1182\/blood-2005-04-1718","article-title":"ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)","volume":"107","author":"Richardson","year":"2006","journal-title":"Blood"},{"issue":"6876","key":"10.1016\/j.cellsig.2022.110331_bb0260","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/416094a","article-title":"Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position","volume":"416","author":"Reif","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cellsig.2022.110331_bb0265","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3324\/haematol.2016.147744","article-title":"The role of ZAP70 kinase in acute lymphoblastic leukemia infiltration into the central nervous system","volume":"102","author":"Alsadeq","year":"2017","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.cellsig.2022.110331_bb0270","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.4049\/jimmunol.177.3.1510","article-title":"Involvement of NFAT1 in B cell self-tolerance","volume":"177","author":"Barrington","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110331_bb0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1600-065X.2010.00936.x","article-title":"Molecular underpinning of B-cell anergy","volume":"237","author":"Yarkoni","year":"2010","journal-title":"Immunol. Rev."},{"issue":"19","key":"10.1016\/j.cellsig.2022.110331_bb0280","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2012-12-474718","article-title":"Targeting B-cell anergy in chronic lymphocytic leukemia","volume":"121","author":"Apollonio","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cellsig.2022.110331_bb0285","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","article-title":"Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status","volume":"109","author":"Mockridge","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellsig.2022.110331_bb0290","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2007-09-111344","article-title":"Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy","volume":"112","author":"Muzio","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellsig.2022.110331_bb0295","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41467-017-00830-y","article-title":"NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia","volume":"8","author":"Marklin","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.cellsig.2022.110331_bb0300","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1074-7613(00)80285-X","article-title":"Different nuclear signals are activated by the B cell receptor during positive versus negative signaling","volume":"6","author":"Healy","year":"1997","journal-title":"Immunity"},{"issue":"6679","key":"10.1016\/j.cellsig.2022.110331_bb0305","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/31960","article-title":"Calcium oscillations increase the efficiency and specificity of gene expression","volume":"392","author":"Dolmetsch","year":"1998","journal-title":"Nature"},{"issue":"6627","key":"10.1016\/j.cellsig.2022.110331_bb0310","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/386855a0","article-title":"Differential activation of transcription factors induced by Ca2+ response amplitude and duration","volume":"386","author":"Dolmetsch","year":"1997","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.cellsig.2022.110331_bb0315","first-page":"1259","article-title":"V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia","volume":"88","author":"Duke","year":"2003","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.cellsig.2022.110331_bb0320","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110331_bb0325","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4049\/jimmunol.158.1.235","article-title":"Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features","volume":"158","author":"Johnson","year":"1997","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cellsig.2022.110331_bb0330","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/modpathol.3800677","article-title":"Immunoglobulin VH somatic hypermutation in mantle cell lymphoma: mutated genotype correlates with better clinical outcome","volume":"19","author":"Lai","year":"2006","journal-title":"Mod. Pathol."},{"issue":"6585","key":"10.1016\/j.cellsig.2022.110331_bb0335","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/381751a0","article-title":"Clonal selection and learning in the antibody system","volume":"381","author":"Rajewsky","year":"1996","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cellsig.2022.110331_bb0340","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0960-9822(95)00025-X","article-title":"Deletion of autoreactive B cells","volume":"5","author":"MacLennan","year":"1995","journal-title":"Curr. Biol."},{"issue":"5638","key":"10.1016\/j.cellsig.2022.110331_bb0345","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cellsig.2022.110331_bb0350","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(94)90331-X","article-title":"Negative selection of lymphocytes","volume":"76","author":"Nossal","year":"1994","journal-title":"Cell"},{"issue":"7552","key":"10.1016\/j.cellsig.2022.110331_bb0355","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nature14231","article-title":"Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia","volume":"521","author":"Chen","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cellsig.2022.110331_bb0360","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm.4062","article-title":"PTEN opposes negative selection and enables oncogenic transformation of pre-B cells","volume":"22","author":"Shojaee","year":"2016","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.cellsig.2022.110331_bb0365","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.20090004","article-title":"Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function","volume":"206","author":"Trageser","year":"2009","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.cellsig.2022.110331_bb0370","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/nm.3247","article-title":"BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint","volume":"19","author":"Swaminathan","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2022.110331_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113393","article-title":"Discovery of a potent, selective, and covalent ZAP-70 kinase inhibitor","volume":"219","author":"Rao","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.cellsig.2022.110331_bb0380","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.4049\/jimmunol.0902844","article-title":"SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells","volume":"184","author":"Brooks","year":"2010","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cellsig.2022.110331_bb0385","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88544","article-title":"A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndrome","volume":"1","author":"Srivastava","year":"2016","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.cellsig.2022.110331_bb0390","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nri2818","article-title":"NFAT, immunity and cancer: a transcription factor comes of age","volume":"10","author":"Muller","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cellsig.2022.110331_bb0395","doi-asserted-by":"crossref","DOI":"10.1172\/JCI135937","article-title":"DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3","volume":"131","author":"Bhansali","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"22","key":"10.1016\/j.cellsig.2022.110331_bb0400","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1021\/acs.jmedchem.8b00185","article-title":"Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors as potential therapeutics","volume":"61","author":"Jarhad","year":"2018","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.cellsig.2022.110331_bb0405","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.molimm.2010.12.007","article-title":"Regulation of BCR signaling","volume":"48","author":"Kurosaki","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellsig.2022.110331_bb0410","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-immunol-042617-053335","article-title":"ZAP-70 in signaling, biology, and disease","volume":"36","author":"Au-Yeung","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.cellsig.2022.110331_bb0415","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/ni.1666","article-title":"Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling","volume":"9","author":"Stadanlick","year":"2008","journal-title":"Nat. Immunol."},{"issue":"6965","key":"10.1016\/j.cellsig.2022.110331_bb0420","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature02119","article-title":"Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice","volume":"426","author":"Sakaguchi","year":"2003","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.cellsig.2022.110331_bb0425","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/eji.200939385","article-title":"Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity","volume":"39","author":"Picard","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.cellsig.2022.110331_bb0430","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph consortium","volume":"111","author":"Ekstrom Smedby","year":"2008","journal-title":"Blood"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656822000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656822000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:07:42Z","timestamp":1760267262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656822000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":86,"alternative-id":["S0898656822000924"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2022.110331","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2022.110331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110331"}}